Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 1.00 |
| ▸ | HDAC3 | O15379 | 2/20 | 1.00 |
| ▸ | HDAC4 | P56524 | 2/20 | 1.00 |
| ▸ | HDAC1 | Q13547 | 2/20 | 1.00 |
| ▸ | HDAC2 | Q92769 | 2/20 | 1.00 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 1.00 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 1.00 |
| ▸ | TNKS | O95271 | 1/20 | 1.00 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 1.00 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 1.00 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 1.00 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 1.00 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 1.00 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 1.00 |
| ▸ | PLIN1 | O60240 | 2/20 | 0.73 |
| ▸ | LMNA | P02545 | 2/20 | 0.73 |
| ▸ | MAPT | P10636 | 2/20 | 0.73 |
| ▸ | RECQL | P46063 | 2/20 | 0.73 |
| ▸ | PLIN5 | Q00G26 | 2/20 | 0.73 |
| ▸ | ABHD5 | Q8WTS1 | 2/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cinnamic Acid SCHEMBL1332 | 1.00 | HCAR2 (1.00) | HCAR2HDAC3HDAC4HDAC1HDAC2 | |
| Cinnamic Acid SCHEMBL653828 | 1.00 | HCAR2 (1.00) | HCAR2HDAC3HDAC4HDAC1HDAC2 | |
| Cinnamic Acid SCHEMBL50466 | 1.00 | HCAR2 (1.00) | HCAR2HDAC3HDAC4HDAC1HDAC2 | |
| Cinnamic Acid SCHEMBL29989544 | 1.00 | HCAR2 (1.00) | HCAR2HDAC3HDAC4HDAC1HDAC2 | |
| Cinnamic Acid SCHEMBL653827 | 1.00 | HCAR2 (1.00) | HCAR2HDAC3HDAC4HDAC1HDAC2 | |
| Cinnamic Acid SCHEMBL1333 | 1.00 | HCAR2 (1.00) | HCAR2HDAC3HDAC4HDAC1HDAC2 | |
| Cinnamic Acid SCHEMBL1706935 | 1.00 | HCAR2 (1.00) | HCAR2HDAC3HDAC4HDAC1HDAC2 | |
| Cinnamic Acid SCHEMBL579400 | 0.97 | HCAR2 (0.95) | HCAR2HDAC3HDAC4HDAC1HDAC2 | |
| Cinnamic Acid SCHEMBL6444122 | 0.97 | HDAC3 (0.95) | HCAR2HDAC3HDAC4HDAC1HDAC2 | |
| Cinnamic Acid SCHEMBL2816036 | 0.97 | HCAR2 (0.95) | HCAR2HDAC3HDAC4HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260051387-A1 | METABOLOMIC ANALYSIS OF PERITONEAL DIALYSIS EFFLUENT | FRESENIUS MEDICAL CARE HOLDINGS, INC. (US) | 2026-02-19 | — | — | US | claimed |
| US-20240350441-A1 | PHARMACEUTICAL FORMULATION AND A PROCESS FOR ITS PREPARATION | Goldlake Lifesciences Pvt Ltd (IN) | 2024-10-24 | — | — | US | claimed |
| CN-118813188-A | Long-opening-time water-soluble formaldehyde-free adhesive and preparation method and application thereof | 江苏艾科赛特新材料有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-118813173-A | Formaldehyde-free adhesive with excellent water resistance and application thereof | 江苏艾科赛特新材料有限公司 | 2024-10-22 | — | — | CN | claimed |
| EP-4440554-A1 | A PHARMACEUTICAL FORMULATION AND A PROCESS FOR ITS PREPARATION | Sava Healthcare Ltd (IN) | 2024-10-09 | — | — | EP | claimed |
| CN-118541170-A | Ionic liquid composition | I2O治疗公司 | 2024-08-23 | — | — | CN | claimed |
| CN-118354764-A | Pharmaceutical preparation and method for producing the same | 萨瓦医疗保健有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-118027276-A | Multipolymer, preparation method and application thereof, negative electrode slurry, negative electrode plate and lithium ion battery | 北京卫蓝新能源科技有限公司 | 2024-05-14 | — | — | CN | claimed |
| US-20230390195-A1 | STABLE COMPOSITIONS FOR INCRETIN MIMETIC COMPOUNDS | DELPOR, INC. | 2023-12-07 | — | — | US | claimed |
| WO-2023099968-A1 | A PHARMACEUTICAL FORMULATION AND A PROCESS FOR ITS PREPARATION | SAVA HEALTHCARE LTD (IN) | 2023-06-08 | — | — | WO | claimed |
| WO-2016049404-A1 | SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049398-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049407-A1 | ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049394-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049396-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049455-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049395-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160090556-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160090557-A1 | SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160089462-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240350441-A1 | PHARMACEUTICAL FORMULATION AND A PROCESS FOR ITS PREPARATION | MYD88, NFATC1, CCR6 | HCAR2 1563/4885HDAC3 3086/4885HDAC4 1152/4885 |
| US-20260051387-A1 | METABOLOMIC ANALYSIS OF PERITONEAL DIALYSIS EFFLUENT | SLC43A1, SLC14A1, SLC1A5 | HCAR2 60/4885HDAC3 3815/4885HDAC4 2450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.